Mitsuyo Maeda Selected Research

Mitsuyo Maeda Research Topics

Disease

4	Ischemia 01/2020 - 04/2003
4	Neoplasms (Cancer) 01/2019 - 02/2006
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 11/2019 - 11/2009
2	Carcinoma (Carcinomatosis) 05/2008 - 02/2006
2	Ganglion Cysts (Ganglion) 02/2008 - 03/2007
2	Infarction (Infarctions) 11/2004 - 07/2003
1	Kidney Diseases (Kidney Disease) 07/2022
1	Aortic Dissection 01/2022
1	Thoracic Aortic Aneurysm 01/2022
1	Mucopolysaccharidosis II (Hunter Syndrome) 11/2019
1	Intellectual Disability (Idiocy) 11/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Reinfection 01/2019
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2015
1	Hyperalgesia 11/2010
1	GM1 Gangliosidosis (Gangliosidosis GM1) 11/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2008
1	Cystitis 04/2008
1	Inflammation (Inflammations) 04/2008
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 03/2007
1	Spinal Cord Injuries (Spinal Cord Injury) 03/2007
1	Coinfection 04/2006
1	Glioma (Gliomas) 04/2006
1	Astrocytoma (Pilocytic Astrocytoma) 04/2006
1	Hyperthermia 02/2006
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2004
1	Peripheral Nerve Injuries 11/2004
1	Brain Ischemia (Cerebral Ischemia) 11/2004
1	Dry Eye Syndromes (Dry Eye Syndrome) 07/2004
1	Cerebral Infarction 07/2003
1	Stroke (Strokes) 04/2003

Drug/Important Bio-Agent (IBA)

2	EpitopesIBA 01/2019 - 07/2004
2	Proteins (Proteins, Gene)FDA Link 04/2006 - 07/2003
2	Messenger RNA (mRNA)IBA 11/2004 - 07/2003
1	OsmiumIBA 07/2022
1	Biological ProductsIBA 07/2022
1	Angiotensin IIIBA 01/2022
1	IntegrinsIBA 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	GlycosaminoglycansIBA 11/2019
1	Lysergic Acid Diethylamide (LSD)IBA 11/2019
1	Chloroquine (Aralen)FDA LinkGeneric 11/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2019
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	NestinIBA 01/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2015
1	cangrelorIBA 11/2010
1	Purinergic P2 Receptors (ADP Receptor)IBA 11/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2008
1	Pancreatitis-Associated ProteinsIBA 04/2008
1	PicibanilIBA 02/2008
1	Carisoprodol (Soma)FDA LinkGeneric 03/2007
1	Cholinergic Agents (Cholinergics)IBA 03/2007
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 03/2007
1	Ganciclovir (Cytovene)FDA LinkGeneric 04/2006
1	Cre recombinaseIBA 04/2006
1	Therapeutic UsesIBA 02/2006
1	damage-induced neuronal endopeptidaseIBA 11/2004
1	MucinsIBA 07/2004
1	SugarsIBA 07/2004
1	Monoclonal AntibodiesIBA 07/2004
1	Activating Transcription Factor 3IBA 07/2003
1	Transcription Factors (Transcription Factor)IBA 07/2003
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2003
1	enhanced green fluorescent proteinIBA 04/2003

Therapy/Procedure

3	Therapeutics 01/2020 - 05/2008
1	Enzyme Replacement Therapy 11/2019
1	Cell Transplantation 11/2009
1	Intravesical Administration 05/2008
1	Aftercare (After-Treatment) 02/2006
1	Radiotherapy 02/2006